Metraipolis › archive › dc_99d0694b5ade

Navigating second-line therapy after immunotherapy in advanced HCC☆ — Europe PMC PMID:41503573

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41503573
DOI
10.1016/j.jhepr.2025.101630
License (as archived)
solo-consultazione
Archived
2026-11-09T09:48:57.115Z
SHA-256 of the archived text
9450271fdfd82b2a9832f33d1714f383b223f5199d4bb89db44194dc709ebf08
Stable URL of this page
https://metraipolis.com/documento/dc_99d0694b5ade

How to cite

Navigating second-line therapy after immunotherapy in advanced HCC☆ — Europe PMC PMID:41503573 — Europe PMC (en), https://europepmc.org/article/MED/41503573 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99d0694b5ade (Metraipolis archive dc_99d0694b5ade, sha256 9450271fdfd82b2a9832f33d1714f383b223f5199d4bb89db44194dc709ebf08)
BibTeX
@misc{dc99d0694b5ade,
  title = {Navigating second-line therapy after immunotherapy in advanced HCC☆ — Europe PMC PMID:41503573},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41503573},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99d0694b5ade; sha256 9450271fdfd82b2a9832f33d1714f383b223f5199d4bb89db44194dc709ebf08},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41503573. Agents can read the archived copy with the MCP tool read_document.